A detailed history of Palo Alto Investors LP transactions in Abeona Therapeutics Inc. stock. As of the latest transaction made, Palo Alto Investors LP holds 108,865 shares of ABEO stock, worth $570,452. This represents 0.1% of its overall portfolio holdings.

Number of Shares
108,865
Previous 12,865 746.21%
Holding current value
$570,452
Previous $81,000 645.68%
% of portfolio
0.1%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$5.55 - $6.67 $532,800 - $640,320
96,000 Added 746.21%
108,865 $604,000
Q3 2024

Nov 14, 2024

BUY
$4.12 - $6.32 $53,003 - $81,306
12,865 New
12,865 $81,000

Others Institutions Holding ABEO

About ABEONA THERAPEUTICS INC.


  • Ticker ABEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,950,380
  • Market Cap $31.2M
  • Description
  • Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...
More about ABEO
Track This Portfolio

Track Palo Alto Investors LP Portfolio

Follow Palo Alto Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Palo Alto Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Palo Alto Investors LP with notifications on news.